Abstract
OBJECTIVE. A study was conducted to determine whether for-profit and not-for-profit freestanding renal dialysis facilities differ with respect to efficiency in the production of dialysis treatments. DATA SOURCES/STUDY SETTING. National data on 1,224 Medicare-certified freestanding dialysis facilities were obtained from the Health Care Financing Administration's (HCFA) 1990 Independent Renal Dialysis Facility Cost Report. Data on Medicare patients receiving care at these facilities during 1990 were obtained from HCFA's End Stage Renal Disease (ESRD) Program Management and Medical Information System (PMMIS). STUDY DESIGN. Ordinary least squares regression (OLS) was used to estimate the association between monthly output of dialysis treatments in 1990 and (a) facility capital and labor inputs, (b) facility ownership characteristics, and (c) case-mix characteristics. DATA COLLECTION/EXTRACTION METHODS. Facility and patient level data were extracted from the Facility Cost Report and the PMMIS databases, respectively. Patient level data were aggregated by facility and merged with facility level data. PRINCIPAL FINDINGS. For-profit sole proprietorships, for-profit partnerships and for-profit corporations each produced significantly more dialysis treatments per month than not-for-profits, adjusting for quantities of resource inputs and case-mix characteristics. CONCLUSION. For-profit facilities appear to be more efficient producers of dialysis treatments than not-for-profits. Further study should address whether other factors such as differences in severity of disease or in quality of care are responsible for these observations.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brancati F. L., Whittle J. C., Whelton P. K., Seidler A. J., Klag M. J. The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. JAMA. 1992 Dec 2;268(21):3079–3084. [PubMed] [Google Scholar]
- Dor A., Held P. J., Pauly M. V. The Medicare cost of renal dialysis. Evidence from a statistical cost function. Med Care. 1992 Oct;30(10):879–891. doi: 10.1097/00005650-199210000-00001. [DOI] [PubMed] [Google Scholar]
- Gardner K. D., Jr Profit and the end-stage renal-disease program. N Engl J Med. 1981 Aug 20;305(8):461–462. doi: 10.1056/nejm198108203050814. [DOI] [PubMed] [Google Scholar]
- Gibson D., McMullan M. End-stage renal disease: a profile of facilities furnishing treatment. Health Care Financ Rev. 1984 Winter;6(2):87–90. [PMC free article] [PubMed] [Google Scholar]
- Goldman F., Grossman M. The production and cost of ambulatory medical care in community health centers. Adv Health Econ Health Serv Res. 1983;4:1–56. [PubMed] [Google Scholar]
- Held P. J., Pauly M. V. Competition and efficiency in the end stage renal disease program. J Health Econ. 1983 Aug;2(2):95–118. doi: 10.1016/0167-6296(83)90001-2. [DOI] [PubMed] [Google Scholar]
- Held P. J., Pauly M. V., Diamond L. Survival analysis of patients undergoing dialysis. JAMA. 1987 Feb 6;257(5):645–650. [PubMed] [Google Scholar]
- Lowrie E. G., Hampers C. L. The success of medicare's end-stage renal-disease program: the case for profits and the private marketplace. N Engl J Med. 1981 Aug 20;305(8):434–438. doi: 10.1056/NEJM198108203050805. [DOI] [PubMed] [Google Scholar]
- Plough A. L., Salem S. R., Shwartz M., Weller J. M., Ferguson C. W. Case mix in end-stage renal disease. Differences between patients in hospital-based and free-standing treatment facilities. N Engl J Med. 1984 May 31;310(22):1432–1436. doi: 10.1056/NEJM198405313102205. [DOI] [PubMed] [Google Scholar]
- Relman A. S. Investor-owned hospitals and health-care costs. N Engl J Med. 1983 Aug 11;309(6):370–372. doi: 10.1056/NEJM198308113090609. [DOI] [PubMed] [Google Scholar]